CompletedNot Applicable

Neuroprotective Study of Electroacupuncture Pretreatment in Patients Undergoing Cardiac Surgery

China300 participantsStarted 2009-12

Plain-language summary

The purpose of this study is to evaluate the neuroprotective effect of electroacupuncture pretreatment in patients undergoing cardiac surgery as an preventive sequela in a randomized and controlled clinical trial. In addition, to investigate the role of inflammatory responses in the precess of the protection.

Who can participate

Age range40 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

This study enrolls a group of 40-65years patients who have heart valve disease who need valve replacement. Inclusion Criteria: * patients who have the indication for aortic or mitral valve replacement * patients would like to accept the follow-up and sign the informed consent * patients with heart function of NYHA I-III degree. Exclusion Criteria: * pregnant or nursing women * comorbid with coronary artery disease * patients with heart function of NYHA IV degree * renal dysfunction with serum creatinine level\>or=2mg/dl(177umol/L) * anticipated life span \< 12 months * enrollment in other clinical trials at the same time not reaching the primary endpoint and probably interference the present trial.

What they're measuring

Cerebrovascular complications and Score of neurological defect

Timeframe: before treatment, after the first treatment, 7, 28days after treatment and follow up at 6 months after treatment

Trial details

NCT IDNCT01020266

SponsorXijing Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-09

View on ClinicalTrials.gov More Stroke trials